Fig. 2From: Is lobectomy superior to sub-lobectomy in non-small cell lung cancer with pleural invasion? A population-based competing risk analysisCumulative incidence curves for the NSCLC patients with PL in overall cases and different subgroups after PSM. Overall patients (A), T2 (B), T3 (C), T4 (D), N0 (E), N1 (F), N2 (G), M0 (H), M1 (I), adenocarcinoma (J), squamous cell carcinoma (K), PL-1 (L), PL-2 (M) and PL-3 (N) cohortsBack to article page